A lot of the attention in medical technology today has been focused on tools and innovations that might help the world better fight the COVID-19 global health pandemic. Today comes news of another startup that is taking on some funding for a disruptive innovation that has the potential to make both COVID-19 as well as other kinds of clinical assessments more accessible.
Nanox, a startup out of Israel that has developed a small, low-cost scanning system and "medical screening as a service" to replace the costly and large machines and corresponding software typically used for X-rays, CAT scans, PET scans and other body imaging services, is today announcing that it has raised $20 million from a strategic investor, South Korean carrier SK Telecom.
SK Telecom in turn plans to help distribute physical scanners equipped with Nanox technology as well as resell the pay-per-scan imaging service, branded Nanox.Cloud, and corresponding 5G wireless network capacity to operate them. Nanox currently licenses its tech to big names in the imaging space like FujiFilm, and Foxconn is also manufacturing its donut-shaped Nanox.Arc scanners.
The funding is technically an extension of Nanox's previous round, which was announced earlier this year at $26 million with backing from Foxconn, FujiFilm and more. Nanox says that the full round is now closed off at $51 million, with the company having raised $80 million since launching almost a decade ago, in 2011.
Nanox's valuation is not being publicly disclosed, a but a news report in the Israeli press from December said that one option the startup was considering was an IPO at a $500 million valuation. We understand from sources that the valuation is about $100 million higher now.